Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionAsset Dedication, LLC
Latest Disclosed Ownership7,594 shares
Latest Disclosed Value $ 2,671,945
Asset Dedication, LLC reports 30.79% decrease in ownership of AMGN / Amgen Inc.

On May 29, 2026 - Asset Dedication, LLC filed a 13F-HR form disclosing ownership of 7,594 shares of Amgen Inc. (MX:AMGN) valued at $2,671,945 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 10,972 shares of Amgen Inc.. This represents a change in shares of -30.79% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F AMGEN COM 031162100 7,594 -3,378 -30.79 2,672 -25.62 0.1871
2026-01-26 2025-12-31 13F AMGEN COM 031162100 10,972 -461 -4.03 3,591 11.31 0.2358
2025-11-20 2025-09-30 13F AMGEN COM 031162100 11,433 -184 -1.58 3,226 -0.52 0.2167
2025-08-19 2025-06-30 13F AMGEN COM 031162100 11,617 409 3.65 3,244 -7.10 0.2355
2025-05-01 2025-03-31 13F AMGEN COM 031162100 11,208 63 0.57 3,492 20.21 0.2834
2025-01-23 2024-12-31 13F AMGEN COM 031162100 11,145 -5,808 -34.26 2,905 -46.83 0.2286
2024-10-15 2024-09-30 13F AMGEN COM 031162100 16,953 -2,138 -11.20 5,462 -8.43 0.3685
2024-08-06 2024-06-30 13F AMGEN COM 031162100 19,091 1,654 9.49 5,965 149,025.00 0.4137
2024-04-16 2024-03-31 13F Amgen Equities 031162100 17,437 -175 -0.99 5 -20.00 0.3709
2024-02-08 2023-12-31 13F Amgen Equities 031162100 17,612 1,499 9.30 5 25.00 0.4123
2023-11-13 2023-09-30 13F Amgen Equities 031162100 16,113 2,156 15.45 4 33.33 0.3688
2023-08-22 2023-06-30 13F Amgen Equities 031162100 13,957 518 3.85 3 0.00 0.2663
2023-04-24 2023-03-31 13F Amgen Equities 031162100 13,439 39 0.29 3 0.00 0.3000
2023-01-19 2022-12-31 13F Amgen Equities 031162100 13,400 1,122 9.14 4 -99.89 0.3586
2022-10-27 2022-09-30 13F Amgen Equities 031162100 12,278 347 2.91 2,751 -4.31 0.3021
2022-07-19 2022-06-30 13F Amgen Equities 031162100 11,931 1,259 11.80 2,875 12.30 0.4271
2022-04-21 2022-03-31 13F Amgen Equities 031162100 10,672 1,486 16.18 2,560 25.43 0.2852
2022-01-21 2021-12-31 13F Amgen Equities 031162100 9,186 963 11.71 2,041 17.30 0.2458
2021-10-18 2021-09-30 13F Amgen Equities 031162100 8,223 -1,056 -11.38 1,740 -22.63 0.2293
2021-07-21 2021-06-30 13F Amgen Equities 031162100 9,279 2,495 36.78 2,249 35.24 0.3350
2021-05-03 2021-03-31 13F Amgen Equities 031162100 6,784 -1,133 -14.31 1,663 -8.48 0.3757
2021-01-28 2020-12-31 13F Amgen Equities 031162100 7,917 1,085 15.88 1,817 3.77 0.3623
2020-10-20 2020-09-30 13F Amgen Equities 031162100 6,832 540 8.58 1,751 18.23 0.3863
2020-08-24 2020-06-30 13F Amgen Equities 031162100 6,292 231 3.81 1,481 20.80 0.4035
2020-05-05 2020-03-31 13F Amgen Equities 031162100 6,061 -171 -2.74 1,226 -18.38 0.3648
2020-01-31 2019-12-31 13F Amgen Equities 031162100 6,232 683 12.31 1,502 40.90 0.4244
2019-10-17 2019-09-30 13F Amgen Equities 031162100 5,549 36 0.65 1,066 4.61 0.3544
2019-07-23 2019-06-30 13F Amgen Equities 031162100 5,513 268 5.11 1,019 2.83 0.3287
2019-04-19 2019-03-31 13F Amgen Equities 031162100 5,245 -12 -0.23 991 -3.03 0.3449
2019-02-12 2018-12-31 13F Amgen Equities 031162100 5,257 -418 -7.37 1,022 -13.02 0.4194
2018-10-26 2018-09-30 13F Amgen Equities 031162100 5,675 400 7.58 1,175 21.01 0.4415
2018-08-13 2018-06-30 13F Amgen Equities 031162100 5,275 24 0.46 971 7.89 0.3316
2018-04-19 2018-03-31 13F Amgen Equities 031162100 5,251 1,350 34.61 900 32.55 0.4464
2018-01-17 2017-12-31 13F Amgen Equities 031162100 3,901 1,203 44.59 679 34.99 0.2734
2017-10-18 2017-09-30 13F Amgen Equities 031162100 2,698 -38 -1.39 503 6.34 0.2425
2017-07-17 2017-06-30 13F Amgen Equities 031162100 2,736 -88 -3.12 473 1.94 0.2379
2017-04-20 2017-03-31 13F Amgen Equities 031162100 2,824 -69 -2.39 464 9.95 0.2506
2017-01-17 2016-12-31 13F Amgen Equities 031162100 2,893 -231 -7.39 422 -19.77 0.2448
2016-11-18 2016-09-30 13F/A-2 Amgen Equities 031162100 3,124 351 12.66 526 24.64 0.3321
2016-10-19 2016-09-30 13F Amgen Equities 031162100 2,916 440
2016-11-18 2016-06-30 13F/A-1 Amgen Equities 031162100 2,773 -143 -4.90 422 -3.43 0.2932
2016-07-14 2016-06-30 13F Amgen Equities 031162100 2,916 440
2016-04-27 2016-03-31 13F Amgen Equities 031162100 2,916 -67 -2.25 437 -9.71 0.3213
2016-02-16 2015-12-31 13F Amgen EQUITIES 031162100 2,983 2,983 484 0.3176
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.